Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease

Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease

Abstract Background The LipiDiDiet trial showed that Souvenaid, a medical food, might delay progression to dementia in prodromal Alzheimer’s disease (AD). The objective of this study was to assess the cost-utility of Souvenaid compared to placebo in patients with prodromal AD under the conditions ap...

Full description

Bibliographic Details
Main Authors: Javier Mar, Ania Gorostiza, Oliver Ibarrondo, Igor Larrañaga, Arantzazu Arrospide, Pablo Martinez-Lage, Myriam Soto-Gordoa
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Alzheimer’s Research & Therapy
Subjects:
Prodromal Alzheimer’s disease
Souvenaid
Cost-utility
Dementia
Clinical dementia rating
Online Access:https://doi.org/10.1186/s13195-020-00737-9

Internet

https://doi.org/10.1186/s13195-020-00737-9

Similar Items